6-((4-Fluorophenyl)(piperidin-1-yl)methyl)-2,3-dihydro-1H-inden-5-ol

ID: ALA4776561

PubChem CID: 162643598

Max Phase: Preclinical

Molecular Formula: C21H24FNO

Molecular Weight: 325.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Oc1cc2c(cc1C(c1ccc(F)cc1)N1CCCCC1)CCC2

Standard InChI:  InChI=1S/C21H24FNO/c22-18-9-7-15(8-10-18)21(23-11-2-1-3-12-23)19-13-16-5-4-6-17(16)14-20(19)24/h7-10,13-14,21,24H,1-6,11-12H2

Standard InChI Key:  NUDOUHHYOQUTRX-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
   14.7775   -8.8464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2577   -9.5097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7775  -10.1688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0003   -9.9183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2953  -10.3269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5862   -9.9183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5862   -9.1011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2953   -8.6925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0003   -9.1011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8771  -10.3269    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8771   -8.6925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8771   -7.8753    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1722   -7.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1722   -6.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8771   -6.2409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5862   -6.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5862   -7.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1722   -9.1011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1722   -9.9183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4631  -10.3269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7540   -9.9183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7540   -9.1011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4631   -8.6925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0490  -10.3269    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  1  9  1  0
  4  9  2  0
  6 10  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 12 17  1  0
 11 12  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 18 23  2  0
 21 24  1  0
 11 18  1  0
  7 11  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4776561

    ---

Associated Targets(Human)

P4HB Tchem Protein disulfide-isomerase (716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-87 MG (3946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 325.43Molecular Weight (Monoisotopic): 325.1842AlogP: 4.60#Rotatable Bonds: 3
Polar Surface Area: 23.47Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 8.50CX Basic pKa: 9.59CX LogP: 4.69CX LogD: 3.75
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.89Np Likeness Score: -0.64

References

1. Shergalis A,Xue D,Gharbia FZ,Driks H,Shrestha B,Tanweer A,Cromer K,Ljungman M,Neamati N.  (2020)  Characterization of Aminobenzylphenols as Protein Disulfide Isomerase Inhibitors in Glioblastoma Cell Lines.,  63  (18): [PMID:32830969] [10.1021/acs.jmedchem.0c00728]

Source